Published in J Clin Invest on June 10, 2013
Mitochondrial Akt Regulation of Hypoxic Tumor Reprogramming. Cancer Cell (2016) 1.41
PI3K therapy reprograms mitochondrial trafficking to fuel tumor cell invasion. Proc Natl Acad Sci U S A (2015) 1.05
Autophagy Promotes Focal Adhesion Disassembly and Cell Motility of Metastatic Tumor Cells through the Direct Interaction of Paxillin with LC3. Cell Rep (2016) 1.01
TRAP1 regulates proliferation, mitochondrial function, and has prognostic significance in NSCLC. Mol Cancer Res (2014) 0.99
Dissecting the Dual Role of AMPK in Cancer: From Experimental to Human Studies. Mol Cancer Res (2015) 0.97
Survivin promotes oxidative phosphorylation, subcellular mitochondrial repositioning, and tumor cell invasion. Sci Signal (2015) 0.92
Chemical Tools to Investigate Mechanisms Associated with HSP90 and HSP70 in Disease. Cell Chem Biol (2016) 0.92
AMPK activity regulates trafficking of mitochondria to the leading edge during cell migration and matrix invasion. Mol Biol Cell (2016) 0.91
Distinctive properties of metastasis-initiating cells. Genes Dev (2016) 0.91
Cofilin drives cell-invasive and metastatic responses to TGF-β in prostate cancer. Cancer Res (2014) 0.89
The vacuolar H+ ATPase is a novel therapeutic target for glioblastoma. Oncotarget (2015) 0.89
Slit/Robo pathway: a promising therapeutic target for cancer. Drug Discov Today (2014) 0.87
Deletion of the mitochondrial chaperone TRAP-1 uncovers global reprogramming of metabolic networks. Cell Rep (2014) 0.87
Molecular Pathways: Mitochondrial Reprogramming in Tumor Progression and Therapy. Clin Cancer Res (2015) 0.86
Targeting hypoxic response for cancer therapy. Oncotarget (2016) 0.85
In vitro models of tumor vessels and matrix: engineering approaches to investigate transport limitations and drug delivery in cancer. Adv Drug Deliv Rev (2013) 0.85
Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer. Cell Death Differ (2016) 0.84
The CT20 peptide causes detachment and death of metastatic breast cancer cells by promoting mitochondrial aggregation and cytoskeletal disruption. Cell Death Dis (2014) 0.84
Synergistic simvastatin and metformin combination chemotherapy for osseous metastatic castration-resistant prostate cancer. Mol Cancer Ther (2014) 0.83
The Mitochondrial Unfoldase-Peptidase Complex ClpXP Controls Bioenergetics Stress and Metastasis. PLoS Biol (2016) 0.82
Autophagy in cancer metastasis. Oncogene (2016) 0.81
Pharmacologic regulation of AMPK in breast cancer affects cytoskeletal properties involved with microtentacle formation and re-attachment. Oncotarget (2015) 0.80
A neuronal network of mitochondrial dynamics regulates metastasis. Nat Commun (2016) 0.79
Combination treatment with doxorubicin and gamitrinib synergistically augments anticancer activity through enhanced activation of Bim. BMC Cancer (2014) 0.79
Transgenic Expression of the Mitochondrial Chaperone TNFR-associated Protein 1 (TRAP1) Accelerates Prostate Cancer Development. J Biol Chem (2016) 0.78
Past, present, and emerging roles of mitochondrial heat shock protein TRAP1 in the metabolism and regulation of cancer stem cells. Cell Stress Chaperones (2016) 0.77
TRAP1 downregulation in human ovarian cancer enhances invasion and epithelial-mesenchymal transition. Cell Death Dis (2016) 0.77
Down-regulation of malignant potential by alpha linolenic acid in human and mouse colon cancer cells. Fam Cancer (2015) 0.77
Disabling mitochondrial reprogramming in cancer. Pharmacol Res (2015) 0.76
Mitochondrial Hsp90s suppress calcium-mediated stress signals propagating from mitochondria to the ER in cancer cells. Mol Cancer (2014) 0.76
Cancer cells exploit adaptive mitochondrial dynamics to increase tumor cell invasion. Cell Cycle (2015) 0.76
Docosahexaenoic Acid Modulates Invasion and Metastasis of Human Ovarian Cancer via Multiple Molecular Pathways. Int J Gynecol Cancer (2016) 0.75
Probing the prostate tumour microenvironment I: impact of glucose deprivation on a cell model of prostate cancer progression. Oncotarget (2017) 0.75
Serine/threonine Kinase Unc-51 Like Kinase-1 (Ulk1) Phosphorylates the Co-chaperone Cdc37 and Thereby Disrupts the Stability of Cdc37 Client Proteins. J Biol Chem (2017) 0.75
The Chaperone TRAP1 As a Modulator of the Mitochondrial Adaptations in Cancer Cells. Front Oncol (2017) 0.75
Autophagy and epithelial-mesenchymal transition: an intricate interplay in cancer. Cell Death Dis (2016) 0.75
Diabetic concentrations of metformin inhibit platelet-mediated ovarian cancer cell progression. Oncotarget (2017) 0.75
Unique fractal evaluation and therapeutic implications of mitochondrial morphology in malignant mesothelioma. Sci Rep (2016) 0.75
Prognostic value of autophagy related proteins ULK1, Beclin 1, ATG3, ATG5, ATG7, ATG9, ATG10, ATG12, LC3B and p62/SQSTM1 in gastric cancer. Am J Transl Res (2016) 0.75
Autophagy Inhibition Delays Early but Not Late-Stage Metastatic Disease. J Pharmacol Exp Ther (2016) 0.75
Inhibition of stress-inducible HSP70 impairs mitochondrial proteostasis and function. Oncotarget (2017) 0.75
Inhibition of mitochondrial matrix chaperones and anti-apoptotic Bcl-2 family proteins empower antitumor therapeutic responses. Cancer Res (2017) 0.75
Mitochondria on the move: emerging paradigms of organelle trafficking in tumour plasticity and metastasis. Br J Cancer (2017) 0.75
CDCP1 drives triple-negative breast cancer metastasis through reduction of lipid-droplet abundance and stimulation of fatty acid oxidation. Proc Natl Acad Sci U S A (2017) 0.75
Syntaphilin controls a mitochondrial rheostat for proliferation-motility decisions in cancer. J Clin Invest (2017) 0.75
Mitochondria in chronic obstructive pulmonary disease and lung cancer: where are we now? Biomark Med (2017) 0.75
Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science (2009) 49.82
TOR signaling in growth and metabolism. Cell (2006) 35.29
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature (2009) 19.65
mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell (2002) 18.22
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol (2011) 15.71
The pathophysiology of mitochondrial cell death. Science (2004) 13.87
Network organization of the human autophagy system. Nature (2010) 11.38
Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science (2010) 11.29
Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell (2008) 11.18
Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha. Science (2009) 10.78
Tumor metastasis: molecular insights and evolving paradigms. Cell (2011) 10.34
Otto Warburg's contributions to current concepts of cancer metabolism. Nat Rev Cancer (2011) 9.68
ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol Biol Cell (2009) 9.24
Genes that mediate breast cancer metastasis to the brain. Nature (2009) 8.23
Cell migration: Rho GTPases lead the way. Dev Biol (2004) 8.20
IDH mutation impairs histone demethylation and results in a block to cell differentiation. Nature (2012) 7.95
LKB1 modulates lung cancer differentiation and metastasis. Nature (2007) 7.80
HSP90 at the hub of protein homeostasis: emerging mechanistic insights. Nat Rev Mol Cell Biol (2010) 7.16
FIP200, a ULK-interacting protein, is required for autophagosome formation in mammalian cells. J Cell Biol (2008) 7.16
The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat Cell Biol (2011) 6.83
Cancer invasion and the microenvironment: plasticity and reciprocity. Cell (2011) 6.36
Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer (2012) 6.14
Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature (2009) 5.32
HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma. Cancer Cell (2008) 4.84
The microcosmos of cancer. Nature (2012) 4.50
Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation. Nature (2012) 4.37
5'-AMP-activated protein kinase (AMPK) is induced by low-oxygen and glucose deprivation conditions found in solid-tumor microenvironments. Mol Cell Biol (2006) 4.28
p21-activated kinases in cancer. Nat Rev Cancer (2006) 4.24
AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress. Nature (2012) 3.85
Energy-dependent regulation of cell structure by AMP-activated protein kinase. Nature (2007) 3.71
The dynamic nature of autophagy in cancer. Genes Dev (2011) 3.57
A role for Drosophila LKB1 in anterior-posterior axis formation and epithelial polarity. Nature (2003) 3.47
Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks. Mol Cell Biol (2011) 3.28
Cellular functions of FAK kinases: insight into molecular mechanisms and novel functions. J Cell Sci (2010) 3.17
Suppression of autophagy by FIP200 deletion inhibits mammary tumorigenesis. Genes Dev (2011) 3.05
Regulation of tumor cell mitochondrial homeostasis by an organelle-specific Hsp90 chaperone network. Cell (2007) 3.00
IAP regulation of metastasis. Cancer Cell (2010) 2.47
Retracted LKB1 and AMPK maintain epithelial cell polarity under energetic stress. J Cell Biol (2007) 2.40
A two-way street: reciprocal regulation of metabolism and signalling. Nat Rev Mol Cell Biol (2012) 2.35
The FERM domain: organizing the structure and function of FAK. Nat Rev Mol Cell Biol (2010) 2.23
Proinvasion metastasis drivers in early-stage melanoma are oncogenes. Cancer Cell (2011) 1.99
Hsp90-Cdc37 chaperone complex regulates Ulk1- and Atg13-mediated mitophagy. Mol Cell (2011) 1.91
Combinatorial drug design targeting multiple cancer signaling networks controlled by mitochondrial Hsp90. J Clin Invest (2009) 1.72
LKB1--a master tumour suppressor of the small intestine and beyond. Nat Rev Cancer (2002) 1.62
The engine driving the ship: metabolic steering of cell proliferation and death. Nat Rev Mol Cell Biol (2010) 1.51
Regulation of focal adhesion kinase by a novel protein inhibitor FIP200. Mol Biol Cell (2002) 1.46
Exploiting the mitochondrial unfolded protein response for cancer therapy in mice and human cells. J Clin Invest (2011) 1.41
FAK phosphorylation at Tyr-925 regulates cross-talk between focal adhesion turnover and cell protrusion. Mol Biol Cell (2011) 1.22
Control of tumor bioenergetics and survival stress signaling by mitochondrial HSP90s. Cancer Cell (2012) 1.17
The long and winding road to rational treatment of cancer associated with LKB1/AMPK/TSC/mTORC1 signaling. Oncogene (2011) 1.13
The alpha-receptor for platelet-derived growth factor as a target for antibody-mediated inhibition of skeletal metastases from prostate cancer cells. Oncogene (2008) 0.94
Emerging roles for mammalian target of rapamycin inhibitors in the treatment of solid tumors and hematological malignancies. Curr Opin Oncol (2011) 0.93
The chemokine receptor CX₃CR1 is directly involved in the arrest of breast cancer cells to the skeleton. Breast Cancer Res (2011) 0.89
Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction. Proc Natl Acad Sci U S A (2005) 7.70
Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol (2005) 6.20
Comparison of BISAP, Ranson's, APACHE-II, and CTSI scores in predicting organ failure, complications, and mortality in acute pancreatitis. Am J Gastroenterol (2009) 3.88
Local-pooled-error test for identifying differentially expressed genes with a small number of replicated microarrays. Bioinformatics (2003) 3.75
Video-assisted sleeve lobectomy for mucoepidermoid carcinoma of the left lower lobar bronchus: a case report. Chest (2002) 3.25
Regulation of tumor cell mitochondrial homeostasis by an organelle-specific Hsp90 chaperone network. Cell (2007) 3.00
An IAP-IAP complex inhibits apoptosis. J Biol Chem (2004) 2.82
Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis. J Clin Invest (2004) 2.59
IAP regulation of metastasis. Cancer Cell (2010) 2.47
Alcohol and smoking as risk factors in an epidemiology study of patients with chronic pancreatitis. Clin Gastroenterol Hepatol (2010) 2.46
End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT Group. J Clin Oncol (2007) 2.41
Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function. J Cell Sci (2002) 2.40
Plasma chromogranin a in patients with inflammatory bowel disease. Inflamm Bowel Dis (2009) 2.37
Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension. J Clin Invest (2005) 2.32
Survivin and molecular pathogenesis of colorectal cancer. Lancet (2003) 2.25
Alcohol consumption, cigarette smoking, and the risk of recurrent acute and chronic pancreatitis. Arch Intern Med (2009) 2.23
The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion. Mol Cell Biol (2005) 2.18
The reverse Warburg effect: glycolysis inhibitors prevent the tumor promoting effects of caveolin-1 deficient cancer associated fibroblasts. Cell Cycle (2010) 2.07
Intrapericardial left pneumonectomy after induction chemotherapy: the risk of cardiac herniation. J Thorac Cardiovasc Surg (2002) 2.05
Full-length dominant-negative survivin for cancer immunotherapy. Clin Cancer Res (2003) 2.00
Organ allocation waiting time during extracorporeal bridge to lung transplant affects outcomes. Chest (2013) 1.99
A p34(cdc2) survival checkpoint in cancer. Cancer Cell (2002) 1.99
Alpha(v)beta3 integrin expression up-regulates cdc2, which modulates cell migration. J Cell Biol (2003) 1.97
Potential regional differences for the tolerability profiles of fluoropyrimidines. J Clin Oncol (2008) 1.92
Multicenter approach to recurrent acute and chronic pancreatitis in the United States: the North American Pancreatitis Study 2 (NAPS2). Pancreatology (2008) 1.87
Regulation of survivin function by Hsp90. Proc Natl Acad Sci U S A (2003) 1.86
Current issues in adjuvant treatment of stage II colon cancer. Ann Surg Oncol (2006) 1.85
Tumor cell dependence on Ran-GTP-directed mitosis. Cancer Res (2008) 1.83
The integrin-growth factor receptor duet. J Cell Physiol (2007) 1.75
Glycolytic cancer associated fibroblasts promote breast cancer tumor growth, without a measurable increase in angiogenesis: evidence for stromal-epithelial metabolic coupling. Cell Cycle (2010) 1.74
Regulation of microtubule stability and mitotic progression by survivin. Cancer Res (2002) 1.74
Rational design of shepherdin, a novel anticancer agent. Cancer Cell (2005) 1.74
Combinatorial drug design targeting multiple cancer signaling networks controlled by mitochondrial Hsp90. J Clin Invest (2009) 1.72
Banking together. A unified model of informed consent for biobanking. EMBO Rep (2008) 1.67
Impact of age on the efficacy of newer adjuvant therapies in patients with stage II/III colon cancer: findings from the ACCENT database. J Clin Oncol (2013) 1.62
Compartmentalized phosphorylation of IAP by protein kinase A regulates cytoprotection. Mol Cell (2007) 1.60
Proximal tibial osteochondromas in patients with fibrodysplasia ossificans progressiva. J Bone Joint Surg Am (2008) 1.59
Fibronectin protects prostate cancer cells from tumor necrosis factor-alpha-induced apoptosis via the AKT/survivin pathway. J Biol Chem (2003) 1.59
Hsp60 regulation of tumor cell apoptosis. J Biol Chem (2007) 1.57
Survivin modulates microtubule dynamics and nucleation throughout the cell cycle. Mol Biol Cell (2006) 1.57
Integrins in prostate cancer progression. Endocr Relat Cancer (2008) 1.56
CX3CR1-fractalkine expression regulates cellular mechanisms involved in adhesion, migration, and survival of human prostate cancer cells. Cancer Res (2004) 1.55
Preclinical model of organotypic culture for pharmacodynamic profiling of human tumors. Proc Natl Acad Sci U S A (2010) 1.55
Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis. Clin Cancer Res (2003) 1.54
Developmental control of apoptosis by the immunophilin aryl hydrocarbon receptor-interacting protein (AIP) involves mitochondrial import of the survivin protein. J Biol Chem (2011) 1.54
Suppression of survivin phosphorylation on Thr34 by flavopiridol enhances tumor cell apoptosis. Cancer Res (2003) 1.54
Pseudohypoparathyroidism and GNAS epigenetic defects: clinical evaluation of albright hereditary osteodystrophy and molecular analysis in 40 patients. J Clin Endocrinol Metab (2010) 1.53
Survival responses of human embryonic stem cells to DNA damage. J Cell Physiol (2009) 1.51
Homing of peripherally injected bone marrow cells in rat after experimental myocardial injury. Haematologica (2003) 1.49
Molecular and immunohistochemical analysis of HER2/neu oncogene in synovial sarcoma. Hum Pathol (2003) 1.47
Does lobectomy for lung cancer in patients with chronic obstructive pulmonary disease affect lung function? A multicenter national study. J Thorac Cardiovasc Surg (2005) 1.47
A functional Notch-survivin gene signature in basal breast cancer. Breast Cancer Res (2008) 1.46
Inhibitor of apoptosis protein survivin regulates vascular injury. Nat Med (2002) 1.42
Exploiting the mitochondrial unfolded protein response for cancer therapy in mice and human cells. J Clin Invest (2011) 1.41
Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma. BMC Cancer (2009) 1.40
Acute ablation of survivin uncovers p53-dependent mitotic checkpoint functions and control of mitochondrial apoptosis. J Biol Chem (2003) 1.37
Survivin as a global target of intrinsic tumor suppression networks. Cell Cycle (2009) 1.36
Survivin gene expression in early-stage non-small cell lung cancer. J Pathol (2003) 1.35
Self-organizing maps for integrated environmental assessment of the Mid-Atlantic region. Environ Manage (2003) 1.32
Met activation in non-small cell lung cancer is associated with de novo resistance to EGFR inhibitors and the development of brain metastasis. Am J Pathol (2010) 1.30
Landscape of the mitochondrial Hsp90 metabolome in tumours. Nat Commun (2013) 1.29
Up-regulation of focal adhesion kinase in non-small cell lung cancer. Lung Cancer (2006) 1.27
Molecular mechanism of inhibition of survivin transcription by the GC-rich sequence-selective DNA binding antitumor agent, hedamycin: evidence of survivin down-regulation associated with drug sensitivity. J Biol Chem (2005) 1.27
Involvement of interleukin-21 in the regulation of colitis-associated colon cancer. J Exp Med (2011) 1.27
Cytoprotective mitochondrial chaperone TRAP-1 as a novel molecular target in localized and metastatic prostate cancer. Am J Pathol (2009) 1.26
Molecular dependence of estrogen receptor-negative breast cancer on a notch-survivin signaling axis. Cancer Res (2008) 1.24
High incidence of benign testicular neoplasms diagnosed by ultrasound. J Urol (2003) 1.23
Molecular and phenotypic characterization of human amniotic fluid cells and their differentiation potential. Cell Res (2006) 1.23
Genome-wide screening of copy number alterations and LOH events in renal cell carcinomas and integration with gene expression profile. Mol Cancer (2008) 1.22
TRAP-1, the mitochondrial Hsp90. Biochim Biophys Acta (2011) 1.22
Heat shock protein 60 regulation of the mitochondrial permeability transition pore in tumor cells. Cancer Res (2010) 1.19
Smoking is underrecognized as a risk factor for chronic pancreatitis. Pancreatology (2011) 1.19
An overview of data integration methods for regional assessment. Environ Monit Assess (2004) 1.18
Natural history following the first attack of acute pancreatitis. Am J Gastroenterol (2012) 1.18
MicroRNA profiling of hepatocarcinogenesis identifies C19MC cluster as a novel prognostic biomarker in hepatocellular carcinoma. Liver Int (2012) 1.18
Selective modulation of type 1 insulin-like growth factor receptor signaling and functions by beta1 integrins. J Cell Biol (2004) 1.17
A survivin gene signature predicts aggressive tumor behavior. Cancer Res (2005) 1.17
Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3beta in colorectal cancer cells. Clin Cancer Res (2005) 1.17
Control of tumor bioenergetics and survival stress signaling by mitochondrial HSP90s. Cancer Cell (2012) 1.17
Direct and indirect effects of retinoic acid on human Th2 cytokine and chemokine expression by human T lymphocytes. BMC Immunol (2006) 1.16
CX3CR1 is expressed by prostate epithelial cells and androgens regulate the levels of CX3CL1/fractalkine in the bone marrow: potential role in prostate cancer bone tropism. Cancer Res (2008) 1.15
beta1A integrin expression is required for type 1 insulin-like growth factor receptor mitogenic and transforming activities and localization to focal contacts. Cancer Res (2005) 1.14
EGFR-targeted therapy for non-small cell lung cancer: focus on EGFR oncogenic mutation. Int J Med Sci (2013) 1.14
The European Consensus on grading of bone marrow fibrosis allows a better prognostication of patients with primary myelofibrosis. Mod Pathol (2012) 1.13
Dendritic cell-based full-length survivin vaccine in treatment of experimental tumors. J Immunother (2007) 1.13